Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Allogene Therapeutics Inc., 3 years.
Allogene Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 5, 2024 | Allogene Therapeutics Inc. | Open-market sale | −9,221 | $2.16 | $19,917 |
| Jun 5, 2024 | Allogene Therapeutics Inc. | Grant or award | +61,475 | — | — |
| May 30, 2024 | Allogene Therapeutics Inc. | Open-market sale | −11,200 | $2.34 | $26,208 |
| Jun 13, 2023 | Allogene Therapeutics Inc. | Grant or award | +74,561 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.